New methods for analyzing tau fibrillization have yielded insights into the biochemical transitions involved in the process. Here we review the parallels between the sequential progression of tau fibrillization observed macroscopically in Alzheimer's disease (AD) lesions and the pathway of tau aggregation observed in vitro with purified tau preparations. In addition, pharmacological agents for further dissection of fibrillization mechanism and lesion formation are discussed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.bbadis.2004.06.016 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!